100%
Thank you in advance for providing thoughtful answers to this questionnaire. This information will help make future ASH meetings even more valuable for your organization and the wider hematology community.
Start
Questions marked with a
*
are required
Contact information
Exhibiting Company Name
First Name
Last Name
Job Title
Phone
Email Address
Website
Select the categories that best represent your organization's products or services (select all that apply)
Artificial Intelligence
Biologicals
Bone Marrow Products
Bone Marrow Transplantation Research
CAR T-cell Therapy
Cell Culture
Cell Separators
Chemotherapy
Clinical Research
Coagulation Products
Data Services
Diagnostic Equipment/Supplies
Diagnostic Services/Testing
Digital Health
Digital Imaging Systems
Flow Cytometry
Gene Therapy
Genetic Testing
Immunotherapy
Market Research
Medical Devices
Medical Technology
Monoclonal Antibodies
Patient Education Materials
Patient Services
Physician Education Materials
Point-of-Care Testing
Precision Medicine
Registry
Research Equipment/Supplies
Research Grants
Research Reagents
Workforce Recruitment
Other, please specify
What are your organization's top three goals and objectives for participating in next year's 2026 ASH Annual Meeting? (select up to 3)
Reach a targeted segment of the hematology community
Enhance brand positioning among healthcare professionals
Identify prescribing opportunities and influence treatment decisions
Promote regulatory approval for new product or indication
Meet with existing collaborators or partners
Share our clinical development pipeline and scientific evidence with the medical community
Gain exposure to scientific research and emerging therapeutic approaches
Recruit employees or collaborators
Conduct competitive intelligence and assess market dynamics
Connect with funding and public-private investment audience
Other, please specify
Does your organization anticipate receiving regulatory approval or expect to launch a new product or service within the next 15 months or at the 2026 ASH Annual Meeting?
Yes
No
If yes, please provide a projected date for the commercial product approval
Will your organization promote, recruit participants, or share updates for a clinical trial within the next 15 months or at the 2026 ASH Annual Meeting?
Yes
No
Unknown at this time
If yes, please identify the drug and trial name
Will your organization recruit job candidates at the 2026 ASH Annual Meeting?
Yes
No
Unknown at this time
Define the Institutional Affiliation of the attendees you aim to connect with at the ASH annual meeting? (select all that apply)
Institutional Affiliation
Federal Health System Entity
Free Standing Health Care Facility
Hospital or Clinical Facility
Medical School/Academic Center
Nonprofit Research Institute
Private Practice
Corporate Research
Define the primary specialty of attendees you aim to connect with at the ASH annual meeting? (select one)
Classical hematology
Malignant hematology
Both
Define the primary discipline of attendees you aim to connect with at the ASH annual meeting? (select all that apply)
Prescribing Clinician
Pathologist
Basic Researcher
Translational Researcher
Clinical Researcher
Define the clinical interests of attendees you aim to connect with at the ASH annual meeting? (select all that apply)
Anemia
Aplastic Anemia/Bone Marrow Failure
Autoimmune Disorders
Bleeding Disorders
Bone Marrow/Stem Cell Transplantation
Leukemia
Low Platelet Counts
Low White Blood Cell Counts
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders
Pediatric Hematology/Oncology
Sickle Cell Disease
Thrombosis and Hemostasis/Blood Clotting
Transfusion Medicine
Other, please specify
Not applicable
Define the research interests of attendees you aim to connect with at the ASH annual meeting? (select all that apply)
Gene Therapy and Transfer
Health Services and Outcomes Research
Hematologic Malignancy
Hematopoiesis
Hemostasis, Thrombosis, and Vascular Wall Biology
Leukocytes, Inflammation, and Immunology
Red Cell Physiology and Disorders
Transfusion Medicine
Transplantation
Other, please specify
Not applicable
What other meetings will your organization exhibit at in 2026? (select all that apply)
American Association of Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
European Hematology Association (EHA)
International Society on Thrombosis and Haemostasis (ISTH)
Society of Hematologic Oncology (SOHO)
Association for the Advancement of Blood and Biotherapies (AABB)
Association for Diagnostics and Laboratory Medicine (ADLM)
Tandem Meetings (Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR)
Other, please specify
Done
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close
drag_indicator
Custom Title
highlight_off